Federal Register / Vol. 66, No. 247 / Wednesday, December 26, 2001 / Notices 66423

[FR Doc. 01–31576 Filed 12–21–01; 8:45 am]

BILLING CODE 4160–01–C

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Orthopaedic and Rehabilitation

Devices Panel of the Medical Devices

Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Orthopaedic and

Rehabilitation Devices Panel of the

Medical Devices Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on January 10, 2002, from 9:30 a.m.

to 5 p.m.

Location: Holiday Inn, Walker/

Whetstone Rooms, Two Montgomery

Village Ave., Gaithersburg, MD.

Contact: Hany W. Demian, Center for

Devices and Radiological Health (HFZ–

410), Food and Drug Administration,

9200 Corporate Blvd., Rockville, MD

20850, 301–594–2036, or FDA Advisory

Committee Information Line, 1–800–

741–8138 (301–443–0572 in the

Washington, DC area), code 12521.

Please call the Information Line for upto-date information on this meeting.

Agenda: The committee will discuss,

make recommendations, and vote on

premarket approval application (PMA)

for a spinal fusion cage with a growth

66424 Federal Register / Vol. 66, No. 247 / Wednesday, December 26, 2001 / Notices

factor soaked in a collagen sponge

intended for use to treat lumbar

degenerative disc disease. Background

information, including the agenda and

questions for the committee, will be

available to the public on January 9,

2002, on the Internet at http://

www.fda.gov/cdrh/panelmtg.html.

Procedure: On January 10, 2002, from

9:30 a.m. to 1 p.m., and from 2 p.m. to

5 p.m., the meeting is open to the

public. Interested persons may present

data, information, or views, orally or in

writing, on issues pending before the

committee. Written submissions may be

made to the contact person by January

4, 2002. Oral presentations from the

public will be scheduled between

approximately 9:30 a.m. and 10 a.m. on

January 10, 2002. Near the end of the

committee deliberations for the PMA, a

30-minute open public session will be

conducted for interested persons to

address issues specific to the

submission before the committee. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before January 4, 2002,

and submit a brief statement of the

general nature of the evidence or

arguments they wish to present, the

names and addresses of proposed

participants, and an indication of the

approximate time requested to make

their presentation.

Closed Presentation of Data: On

January 10, 2002, from 1 p.m. to 2 p.m.,

the meeting will be closed to the public

to permit the committee to discuss and

review trade secret and/or confidential

commercial information presented by a

sponsor (5 U.S.C. 552b(c)(4)).

FDA regrets that it was unable to

publish this notice 15 days prior to the

January 10, 2002, Orthopaedic and

Rehabilitation Devices Panel of the

Medical Devices Advisory Committee

meeting. Because the agency believes

there is some urgency to bring this issue

to public discussion and qualified

members of the Orthopaedic and

Rehabilitation Devices Panel of the

Medical Devices Advisory Committee

were available at this time, the

Commissioner of Food and Drugs

concluded that it was in the public

interest to hold this meeting even if

there was not sufficient time for the

customary 15-day public notice.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: December 18, 2001.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 01–31578 Filed 12–21–01; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF THE INTERIOR

Office of the Secretary

Delaware and Lehigh Heritage Corridor

Commission Meeting

AGENCY: Department of Interior, Office

of the Secretary.

ACTION: Notice of meeting.

SUMMARY: This notice announces an

upcoming meeting of the Delaware &

Lehigh National Heritage Corridor

Commission. Notice of this meeting is

required under the Federal Advisory

Committee Act (Public Law 92–463).

Meeting Date and Time: Friday,

January 11, 2002, Time 1:30 p.m. to 4

p.m.

Address: Bethlehem Township

Municipal Building, 4225 Easton

Avenue, Bethlehem PA 18020.

The agenda for the meeting will focus

on implementation of the Management

Action Plan for the Delaware and

Lehigh National Heritage Corridor and

State Heritage Park. The Commission

was established to assist the

Commonwealth of Pennsylvania and its

political subdivisions in planning and

implementing an integrated strategy for

protecting and promoting cultural,

historic and natural resources. The

Commission reports to the Secretary of

the Interior and to Congress.

FOR FURTHER INFORMATION CONTACT: C.

Allen Sachse, Executive Director,

Delaware & Lehigh National Heritage

Corridor Commission, 10 E. Church

Street, Room A–208, Bethlehem, PA

18018, (610) 861–9345.

SUPPLEMENTARY INFORMATION: The

Delaware & Lehigh National Heritage

Corridor Commission was established

by Public Law 100–692, November 18,

1988 and extended through Public Law

105–355, November 13, 1998.

Dated: December 18, 2001.

C. Allen Sachse,

Executive Director, Delaware & Lehigh

National Heritage Corridor Commission.

[FR Doc. 01–31585 Filed 12–21–01; 8:45 am]

BILLING CODE 6820–PE–M

INTERNATIONAL TRADE

COMMISSION

[Inv. No. 337–TA–459]

In the Matter of Certain Garage Door

Operators Including Components

Thereof; Notice of Decision to Modify

an Initial Determination Granting a

Motion to Intervene

AGENCY: U.S. International Trade

Commission.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the U.S. International Trade

Commission has determined to modify

an initial determination (ID) (Order No.

5), as supplemented by Order No. 7,

issued by the presiding administrative

law judge (ALJ) in the above-captioned

investigation. The ID is modified to the

extent that the restrictions placed an

intervenor’s participation in the

investigation are lifted.

FOR FURTHER INFORMATION CONTACT: Jean

Jackson, Esq., Office of the General

Counsel, U.S. International Trade

Commission, 500 E Street, SW.,

Washington, DC 20436, telephone 202–

205–3104. Copies of all nonconfidential

documents filed in connection with this

investigation are or will be available for

inspection during official business

hours (8:45 a.m. to 5:15 p.m.) in the

Office of the Secretary, U.S.

International Trade Commission, 500 E

Street SW., Washington, DC 20436,

telephone 202–205–2000. General

information concerning the Commission

may also be obtained by accessing its

Internet server (http://www.usitc.gov).

The public record for this investigation

may be viewed on the Commission’s

electronic docket (EDIS–ON–LINE) at

http://dockets.usitc.gov/eol.public.

Hearing-impaired persons are advised

that information on the matter can be

obtained by contacting the

Commission’s TDD terminal on 202–

205–1810.

SUPPLEMENTARY INFORMATION: The

Commission instituted this investigation

on July 16, 2001, based on a complaint

filed by The Chamberlain Group, Inc.

(‘‘Chamberlain’’) against six entities, not

including Microchip Technology Inc.

(Microchip). 66 FR 37704.

Chamberlain’s complaint alleges

violations of section 337 in the

importation into the United States, sale

for importation, and/or sale within the

United States after importation of

certain garage door operators by reason

of infringement of certain claims of

Chamberlain’s U.S. Letters Patents Nos.

Re. 35,364 and Re. 36,703. On August 6,

2001, Microchip filed a motion to

intervene in this investigation.

On October 1, 2001, the ALJ issued an

ID (Order No. 5) granting Microchip’s

motion. The ID allowed Microchip to

become an ‘‘intervenor’’ in the present

investigation, but placed restrictions on

Microchip’s participation. Under the ID,

Microchip was allowed to participate in

the discovery phase of the investigation,

but was not allowed to notice

depositions during discovery or

participate as a party at the hearing. On

October 30, 2001, the Commission